Invention Grant
US09573948B2 Triazolopyridine compounds and methods for the treatment of cystic fibrosis
有权
三唑并吡啶化合物和治疗囊性纤维化的方法
- Patent Title: Triazolopyridine compounds and methods for the treatment of cystic fibrosis
- Patent Title (中): 三唑并吡啶化合物和治疗囊性纤维化的方法
-
Application No.: US14876428Application Date: 2015-10-06
-
Publication No.: US09573948B2Publication Date: 2017-02-21
- Inventor: Bridget M. Cole , Richard A. Nugent , Paul T. Smith, Jr.
- Applicant: FLATLEY DISCOVERY LAB
- Applicant Address: US MA Charlestown
- Assignee: Flatley Discovery Lab
- Current Assignee: Flatley Discovery Lab
- Current Assignee Address: US MA Charlestown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore, Esq.
- Main IPC: C07D471/02
- IPC: C07D471/02 ; C07D471/04 ; A61K31/437 ; A61K31/496 ; A61K45/06 ; A61K31/4196 ; A61K31/4439
Abstract:
The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
Public/Granted literature
- US20160096835A1 TRIAZOLOPYRIDINE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS Public/Granted day:2016-04-07
Information query
